AcouSort (ACOU.ST) Stock Analysis & AI Equity Report
AcouSort (ACOU.ST) overview
AcouSort (ACOU.ST) stock analysis and AI equity research. For the latest completed financial year, 2025, AcouSort reported revenue of SEK 6.9m and operating profit of SEK -14.5m; the year-end share price was 2.83 SEK and market capitalisation was SEK 53.4m. AcouSort is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get AcouSort's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2026-05-21. Data will be refreshed during report generation.
About AcouSort
AcouSort AB develops acoustofluidic products and solutions for the automated preparation of biological samples. Its technology uses sound waves and microfluidics to separate, concentrate, purify and stain cells, exosomes and bacteria. The company sells separation modules for diagnostic system manufacturers and research instruments for sample processing in laboratory and point-of-care applications.
Generate the AcouSort report
AcouSort is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for AcouSort and represent the latest completed financial year (2025). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.